{Reference Type}: Letter
{Title}: Response to Hasan et al's "Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: A retrospective cohort study".
{Author}: Shih PC;Wei JCC;
{Journal}: J Am Acad Dermatol
{Volume}: 0
{Issue}: 0
{Year}: 2024 Aug 6
{Factor}: 15.487
{DOI}: 10.1016/j.jaad.2024.06.076